Open AccessBioprosthetic mitral valve thrombosis not prevented by novel oral anticoagulant and successfully treated with heparin
Author(s) -
Lixi Caspary,
Gino Lee,
Sonja Matter-Ensner,
Omer Dzemali,
Alain Bernheim
Publication year - 2020
Publication title -
cardiovascular medicine
Language(s) - English
Resource type - Journals
eISSN - 1664-204X
pISSN - 1664-2031
DOI - 10.4414/cvm.2020.02114
Subject(s) - medicine , thrombus , heparin , thrombosis , cardiology , cusp (singularity) , phenprocoumon , anticoagulant , prosthesis , atrial fibrillation , surgery , warfarin , geometry , mathematics
All echocardiographic evidence of bioprosthesis thrombosis disappeared during the 48 hours of intravenous treatment with unfractionated heparin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom